| Database ID | Agent | Target | Cancer Type | Detail |
| DB00871 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | liver cancer | view |
| DB00872 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
| DB00873 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
| DB00874 | everolimus | Serine/threonineprotein kinase mTOR | gastric cancer | view |
| DB00875 | volasertib | Serine/threonineprotein kinase PLK1 | advanced solid tumors | view |
| DB00876 | vandetanib | Epidermal growth factor receptor
Vascular endothelial growth factor receptor 2
Protooncogene tyrosineprotein kinase receptor ret | liver cancer | view |
| DB00877 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | liver cancer | view |
| DB00878 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | liver cancer | view |
| DB00879 | bevacizumab | Vascular endothelial growth factor | liver cancer | view |
| DB00880 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | liver cancer | view |
| DB00881 | cetuximab | Epidermal growth factor receptor | biliary tract and gallbladder cancer | view |
| DB00882 | panitumumab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00883 | BIBF 1120 | VEGFR 13, FGFR 13, PDFGR ¦Á and ¦Â | prostate cancer | view |
| DB00884 | cetuximab | Epidermal growth factor receptor | melanoma | view |
| DB00885 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | head and neck cancer | view |